OnabotulinumtoxinA in the treatment of overactive bladder : a cost-effectiveness analysis versus best supportive care in England and Wales
Year of publication: |
September 2016
|
---|---|
Authors: | Freemantle, Nick ; Khalaf, Kristin ; Loveman, Clara ; Stanisic, Sanja ; Gultyaev, Dmitry ; Lister, Johanna ; Drake, Marcus |
Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 17.2016, 7, p. 911-921
|
Subject: | Overactive bladder | OnabotulinumtoxinA | Incontinence | Cost-effectiveness | Kosten-Wirksamkeits-Analyse | Cost-effectiveness analysis | Gesundheitskosten | Health care costs |
-
Cost-effectiveness and estimated health benefits of treating patients with vitamin D in pre-dialysis
Snyder, Sophie, (2020)
-
Aksan, Anna-Maria, (2022)
-
Why perspective matters in health outcomes research analyses
Polimeni, John M., (2013)
- More ...
-
Hamid, Rizwan, (2015)
-
Freemantle, Nick, (1999)
-
A framework for incorporating cost-effectiveness in evidence-based clinical practice guidelines
Mason, James, (1999)
- More ...